Murphy & Mullick Capital Management Corp

Position in ROIV — Roivant Sciences Ltd.

CIK 2047271 SMITHTOWN, NY

Position in ROIV

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,539

+$769 QoQ

Shares Held

100

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#446

of 494 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Murphy & Mullick Capital Management Corp holds $1,730,688 across 5 Biotechnology names. ROIV ranks #5 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	3,143	$1,561,222
2	REGN	Regeneron Pharmaceuticals, Inc.	240	$149,649
3	MRNA	Moderna, Inc.	139	$9,734
4	CRSP	CRISPR Therapeutics AG	120	$6,544
5	ROIV	Roivant Sciences Ltd. This page	100	$3,539

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,539	100	0.0%	Shares	Sole	2026-08-14
2026-03-31	$2,770	100	0.0%	Shares	Sole	2026-04-17
2025-12-31	$2,170	100	0.0%	Shares	Sole	2026-02-10
2025-09-30	$1,513	100	0.0%	Shares	Sole	2025-11-07
2025-06-30	$1,127	100	0.0%	Shares	Sole	2025-08-14
2025-03-31	$1,009	100	0.0%	Shares	Sole	2025-05-14
2024-12-31	$1,183	100	—	Shares	Sole	2025-02-12
No filing history on record for this holder in this stock.